The legislature's own summary of the bill, or its official long title.
Board of Pharmacy; regulation of crystalline polymorph psilocybin. Directs the Board of Pharmacy to promulgate regulations that allow for prescribing, dispensing, possessing, and using the pharmaceutical composition of crystalline polymorph psilocybin upon approval by the U.S. Food and Drug Administration and following rescheduling by the U.S. Drug Enforcement Administration.
Every action
39 steps, oldest first, as the legislature records them.
Show the 31 earlier steps
SenatePrefiled and ordered printed; Offered 01-08-2025 25102713D
CommitteeReferred to Committee on Education and Health · Senate Education and Health
SenateAssigned Education sub: Health Professions
SenateFiscal Impact Statement from Department of Planning and Budget (SB1135)
CommitteeReported from Education and Health with substitute (15-Y 0-N) · Senate Education and Health15–0 vote
SenateCommittee substitute printed 25105086D-S1
SenateFiscal Impact Statement from Department of Planning and Budget (SB1135)
SenateRules suspended
SenateConstitutional reading dispensed (on 1st reading) (39-Y 0-N)39–0 vote
SenatePassed by for the day
SenateRead second time
SenateReading of substitute waived
SenateEducation and Health Substitute agreed to
SenateEngrossed by Senate - committee substitute
SenateRules suspended
SenateConstitutional reading dispensed (on 3rd reading) (40-Y 0-N)40–0 vote
From Virginia's official records (lis.blob.core.windows.net), checked Nov 13, 2026.
Text links go to the official versions; LegiList does not copy bill text.